22JPM

ElastiMed to Participate at ACCESS CHINA Biotech Forum

By Yafo Life Sciences

January 6th, 2022 (Shanghai) — We are glad to announce that Omer Zelka, the CEO of ElastiMed, has been invited to showcase at ACCESS CHINA Biotech Forum during Jan 4th – Jan14th. ACCESS CHINA Biotech Forum is the largest online corporate access event between China and the western biopharma industry.

If you are interested in listening to the live event, please register at https://biotochina.org/register/

About ElastiMed

ElastiMed has developed a wearable medical device, designed to improve circulation in the legs, treating patients suffering from venous and lymphatic diseases. The device is based on a Smart Material technology, to continuously massage the legs throughout the day, without disturbing the patient’s daily routine. Integrated sensors monitor the patient’s condition, to increase patient’s engagement and allowing for personalized treatment and remote monitoring. The device is expected to provide a comfortable and effective treatment option to treat leg swelling, prevent complications and improve the quality of life.


About ACCESS CHINA

ACCESS CHINA is the most effective deal-making platform for Western pharma and biotech leaders looking to enter or expand in the Chinese market. ACCESS CHINA creates invaluable BD opportunities by directly connecting and meeting with the right partners for development, licensing or commercial collaborations. View more information at https://biotochina.org/access-china-forum/


Contact US

Register ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum

For more information, please contact:

Wendi Xiang

Wxiang@yafocapital.com